The International ME/CFS Conference 2025 has concluded. You may still register in order to receive a notification once presentations are available on demand on our website.
Profile
Dr (MD) Laura Kim
Charité – Universitätsmedizin Berlin, Germany
Website Presentation
11:15 CEST / Session: Treatment II: Clinical trials
Hyperbaric oxygen therapy (HBOT) trial in ME/CFS
Dr Laura Kim was previously acting as a physician and researcher at the Institute of Medical Immunology at Charité – University Medicine Berlin in Germany, where she was a member of Prof Carmen Scheibenbogen's research group on "Clinical Immunology and Immune Monitoring". In her previous role, she acted as the coordinator of several clinical trials implemented within the framework of the National Clinical Studies Group ME/CFS and Post-COVID Syndrom (NKSG) at Charité.
